Norges Bank
PASG icon

Norges Bank’s Passage Bio PASG Stock Holding History

Norges Bank’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,920
Closed -$119K – 2139
2022
Q1 		$119K Sell
1,920
-1,430
-43% -$118K ﹤0.01% 2153
2021
Q4 		$425K Sell
3,350
-5,870
-64% -$959K ﹤0.01% 2153
2021
Q3 		$1.84M Buy
9,220
+3,666
+66% +$874K ﹤0.01% 2064
2021
Q2 		$1.47M Buy
5,554
+4,345
+359% +$1.34M ﹤0.01% 2057
2021
Q1 		$423K Sell
1,209
-461
-28% -$197K ﹤0.01% 2096
2020
Q4 		$854K Buy
+1,670
New +$669K ﹤0.01% 2044
2020
Q3 		– Sell
-1,000
Closed -$547K – 2153
2020
Q2 		$547K Hold
1,000
– – ﹤0.01% 2044
2020
Q1 		$315K Buy
+1,000
New +$313K ﹤0.01% 2028

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank's PASG Position: Q2 2022 in Review

Norges Bank sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 1,920 shares — an estimated $119K sold.

Norges Bank first reported a position in PASG in Q1 2020 and held it in 8 quarters. The position peaked at $1.84M in Q3 2021. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • Norges Bank reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • Norges Bank sold 1,920 Passage Bio shares in Q2 2022, an estimated $119K.
  • Norges Bank first reported a position in Passage Bio in Q1 2020 and held it in 8 quarters.
  • Norges Bank's Passage Bio position peaked at $1.84M in Q3 2021.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Norges Bank's 13F filing for Q2 2022, filed 11 Aug 2022.